Furthermore, the rodents had lower levels of inflammation in the brain, a slowed down rate of nerve cell loss and more protection of the nerve cells.
“These very promising outcomes demonstrate the efficacy of these novel multiple receptor drugs that originally were developed to treat type 2 diabetes but have shown consistent neuro-protective effects in several studies,” lead researcher Christian Holscher said in the release.
Researchers now want to continue their investigations and hope to yield the same results with humans and other drugs.
“Here we show that a novel triple receptor drug shows promise as a potential treatment for Alzheimer’s,” Holscher added, “but further dose-response tests and direct comparisons with other drugs have to be conducted in order to evaluate if this new drugs is superior to previous ones.”
» RELATED: Study: Here's why marriage is linked to a lower risk of dementia